Roivant Sciences's total assets for Q1 2024 were $6.50B, a decrease of -10.05% from the previous quarter. ROIV total liabilities were $601.16M for the fiscal quarter, a -22.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.